rs6715729
Variant in the TACR1 gene (Tachykinin Receptor 1 (NK1R))
rs6715729 is a single nucleotide polymorphism (SNP) in the TACR1 gene, involved in substance P signaling. Variants at this position have been studied in relation to immune function, metabolism, and chronic illness.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is the rs6715729 variant?
rs6715729 is a SNP (single nucleotide polymorphism) in the TACR1 (Tachykinin Receptor 1 (NK1R)) gene. It belongs to the Pain Sensory category and is part of the Pain & Sensory Processing biological cluster. TACR1 encodes the NK1 receptor for substance P, a neuropeptide mediating pain transmission, inflammation, and stress responses.
Biological role and pathway
This variant sits within the TACR1 gene, which is involved in the substance P signaling pathway. Genes within the Pain & Sensory Processing cluster work together to maintain balanced function across interconnected biological systems.
Variants in genes within this pathway may influence an individual's predisposition to altered function — particularly under conditions of physiological stress such as viral infection or prolonged illness.
rs6715729 and Long COVID / ME-CFS research
Substance P/NK1R signaling promotes neurogenic inflammation and mast cell activation that may amplify symptoms in Long COVID.
This information is based on published research and does not constitute medical advice. See references below.
Parent gene: TACR1
rs6715729 is one of 1 known variant in the TACR1 gene. To understand the full biological context of this variant, explore the parent gene page.
View TACR1 gene page →Conditions studied in relation to rs6715729
Research into TACR1 variants including rs6715729 has explored associations with the following conditions. These are areas of scientific investigation and do not imply causation.
Genetic insights from DNA data
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may include TACR1 and the rs6715729 variant.
The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. Results are presented in plain English with appropriate scientific context, no medical jargon, no scare tactics. All results should be discussed with a qualified healthcare provider.
Frequently asked questions
What is the rs6715729 variant in the TACR1 gene?
rs6715729 is a single nucleotide polymorphism (SNP) located in the TACR1 (Tachykinin Receptor 1 (NK1R)) gene, which is involved in substance P signaling. TACR1 encodes the NK1 receptor for substance P, a neuropeptide mediating pain transmission, inflammation, and stress responses.
How may the rs6715729 variant relate to Long COVID or ME/CFS?
Substance P/NK1R signaling promotes neurogenic inflammation and mast cell activation that may amplify symptoms in Long COVID.
Can a consumer DNA test detect the rs6715729 variant?
Many consumer DNA tests such as 23andMe, AncestryDNA, and MyHeritage genotype common SNPs. ChronicDNA analyses your raw DNA file and reports on variants studied in relation to chronic illness, immune function, and metabolism. This is not a diagnostic service — results are informational and educational only.
Find out if you carry the rs6715729 variant
Upload your DNA data from 23andMe, AncestryDNA, or MyHeritage and receive a personalised report covering >80 genes relevant to Long COVID and ME/CFS.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
References
The following publications were used in compiling the research context for TACR1 and its variants. This is not an exhaustive literature review.
- [1]PMID: 32272069
- [2]Nature Genetics
- [3]Journal of Clinical Investigation